We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+20.49%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
AUM
$201M
AUM Growth
+$149M
Cap. Flow
+$143M
Cap. Flow %
71%
Top 10 Hldgs %
12.72%
Holding
641
New
154
Increased
108
Reduced
3
Closed
376

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.86M
2
LHX icon
L3Harris
LHX
+$2.73M
3
SRE icon
Sempra
SRE
+$2.69M
4
CME icon
CME Group
CME
+$2.65M
5
GPN icon
Global Payments
GPN
+$2.53M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$760K
2
AEP icon
American Electric Power
AEP
+$752K
3
PG icon
Procter & Gamble
PG
+$749K
4
V icon
Visa
V
+$715K
5
EA icon
Electronic Arts
EA
+$650K

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Financials 15.1%
3 Healthcare 13.84%
4 Consumer Discretionary 10.58%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRT icon
226
Vertiv
VRT
$101B
$264K 0.13%
+19,463
New +$227K
MRNA icon
227
Moderna
MRNA
$21.9B
$261K 0.13%
4,067
+2,432
+149% +$133K
VRSN icon
228
VeriSign
VRSN
$27B
$258K 0.13%
+1,247
New +$259K
SSB icon
229
SouthState Bank Corp
SSB
$10.5B
$257K 0.13%
+5,387
New +$281K
FCN icon
230
FTI Consulting
FCN
$4.37B
$248K 0.12%
+2,163
New +$262K
CRUS icon
231
Cirrus Logic
CRUS
$6.42B
$247K 0.12%
3,995
+2,544
+175% +$174K
PODD icon
232
Insulet
PODD
$11.8B
$245K 0.12%
+1,263
New +$241K
SMG icon
233
ScottsMiracle-Gro
SMG
$3.97B
$245K 0.12%
+1,821
New +$235K
CDK
234
DELISTED
CDK Global, Inc.
CDK
$245K 0.12%
5,908
+4,512
+323% +$174K
SUI icon
235
Sun Communities
SUI
$15.1B
$240K 0.12%
+1,772
New +$235K
CACI icon
236
CACI
CACI
$11.3B
$236K 0.12%
+1,088
New +$260K
DRE
237
DELISTED
Duke Realty Corp.
DRE
$235K 0.12%
+6,650
New +$227K
TOL icon
238
Toll Brothers
TOL
$14.1B
$232K 0.12%
+7,116
New +$195K
HUN icon
239
Huntsman Corp
HUN
$1.76B
$230K 0.11%
+12,777
New +$214K
RSG icon
240
Republic Services
RSG
$64.5B
$230K 0.11%
2,808
+1,837
+189% +$148K
PPC icon
241
Pilgrim's Pride
PPC
$6.65B
$225K 0.11%
13,328
+12,530
+1,570% +$244K
PAYC icon
242
Paycom
PAYC
$7.86B
$218K 0.11%
+704
New +$187K
ALNY icon
243
Alnylam Pharmaceuticals
ALNY
$29.5B
$216K 0.11%
+1,460
New +$197K
ACAD icon
244
Acadia Pharmaceuticals
ACAD
$4.39B
$215K 0.11%
+4,445
New +$213K
FOLD
245
DELISTED
Amicus Therapeutics
FOLD
$215K 0.11%
+14,270
New +$174K
CZR icon
246
Caesars Entertainment
CZR
$6.06B
$213K 0.11%
+5,322
New +$147K
AGCO icon
247
AGCO
AGCO
$7.28B
$211K 0.1%
+3,805
New +$198K
POST icon
248
Post Holdings
POST
$4.09B
$211K 0.1%
3,675
+3,612
+5,733% +$210K
EWBC icon
249
East-West Bancorp
EWBC
$18.1B
$210K 0.1%
+5,801
New +$194K
ARW icon
250
Arrow Electronics
ARW
$11.1B
$208K 0.1%
+3,021
New +$191K

Similar funds

Pearl River Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Pearl River Capital held 641 positions worth $201M, up 288% from $51.8M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Pearl River Capital deployed $143M of net new capital in Q2 2020, opening 154 new positions and adding to 108 existing holdings. Its largest new stake was Biogen: 9,509 shares worth $2.54M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Applied Materials, an estimated $458K trimmed.

  • Pearl River Capital's largest Q2 2020 buy was Biogen: 9,509 shares worth $2.54M.
  • Pearl River Capital added most to L3Harris in Q2 2020, an estimated $2.73M increase.
  • Pearl River Capital's biggest Q2 2020 reduction was Applied Materials, cutting an estimated $458K.
  • Pearl River Capital fully exited Gilead Sciences in Q2 2020, selling an estimated $760K.
  • Pearl River Capital's ten largest holdings make up 13% of its $201M portfolio in Q2 2020.
  • Pearl River Capital opened 154 new positions and closed 376 in Q2 2020.
  • Pearl River Capital's portfolio value rose 288% quarter-over-quarter to $201M.

Based on Pearl River Capital's 13F filing for Q2 2020, filed 10 Aug 2020.